Ainhoa Erce-Llamazares

A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

Marta Compte, Seandean L. Harwood, Inés G. Muñoz et al. · Nature Communications · 2018 · 141 citations · Full text

Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers

Belén Blanco, Ángel Ramírez-Fernández, Clara Bueno et al. · Cancer Immunology Research · 2022 · 31 citations · Full text

An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity

Marta Compte, Seandean L. Harwood, Ainhoa Erce-Llamazares et al. · Clinical Cancer Research · 2021 · 24 citations

A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response

Laura Rubio‐Pérez, Rodrigo Lázaro‐Gorines, Seandean L. Harwood et al. · OncoImmunology · 2023 · 15 citations · Full text

Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity

Oana Hangiu, Marta Compte, Anders Dinesen et al. · iScience · 2022 · 14 citations · Full text